IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding IO Biotech, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 15 | 19 | +4 |
| Shares | 12.2M | 29.7M | +17.4M (+142.3%) |
| Value | $24.0M | $41.7M | +$17.7M (+74.1%) |
New holders (8)
Institutions that held IO Biotech, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,148,000 | $3.03M | 0.09% |
| Marshall Wace, LLP | 2,105,262 | $2.91M | 0.01% |
| Stonepine Capital Management, LLC | 1,975,308 | $2.79M | 0.93% |
| Alyeska Investment Group, L.P. | 987,654 | $1.39M | 0.01% |
| Pivotal bioVenture Partners Investment Advisor LLC | 864,197 | $1.22M | 0.49% |
| Logos Global Management LP | 493,827 | $696.3K | 0.10% |
| XTX Topco Ltd | 21,238 | $29.3K | 0.01% |
| Wealth Enhancement Advisory Services, LLC | 10,100 | $14.2K | 0.00% |
Sold out (4)
Institutions that held IO Biotech, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Aureus Asset Management, LLC | 43,744 | $85.5K |
| Summit Trail Advisors, LLC | 43,744 | $85.5K |
| Citadel Advisors LLC | 37,690 | $73.9K |
| Two Sigma Securities, LLC | 13,020 | $25.5K |